.OS Therapies will specify on the NYSE American supply exchange this morning by means of a $6.4 thou...
.ALX Oncology's phase 2 gastric cancer feedback price has diminished. After observing its CD47 block...
.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has disappointed desires, motivatin...
.While Biogen's pharma peers are looking for late-stage properties along with little bit of risk, ch...
.Instil Bio has actually been actually a biotech trying to find a pipe after it junked its lead asse...
.Biogen has actually returned liberties to an early Alzheimer's disease program to Denali Therapies,...
.Welcome to this week's Chutes & Ladders, our roundup of considerable management hirings, firings...
.Vertex's effort to alleviate an uncommon genetic disease has reached one more trouble. The biotech ...
.Vir Medical's second-quarter earnings record wasn't short of major headlines. The company accepted ...
.Galapagos has paused enrollment in a trial of a BCMA-directed CAR-T cell treatment, pumping the bra...